Enveric Biosciences
ENVB----
Enveric Biosciences (ENVB)
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psych...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Enveric Biosciences Analyst Rating
View MoreForecast & Rating
Mar 6, 2025Price forecast
$120.009275.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jun 29 at 07:01 AM
Enveric Biosciences CEO joins B. Riley Securities neuropsychiatry fireside chat at Mind, Muscle & Vision Summit
- StockTitan · Jun 16 at 12:28 AM
Enveric Biosciences Announces Participation in 2026 BIO International Convention | ENVB Stock News
- Tip Ranks · Jun 9 at 05:51 PM
Enveric Biosciences Expands At-The-Market Equity Offering
- benzinga_article · May 19 at 12:34 PM
Enveric Biosciences shares are trading lower. The company announced preclinical in vitro results showing no photoreactive potential for EB‑003, further derisking its neuropsychiatric program.
- Earnings Watch · May 15 at 07:02 AM
Enveric Biosciences | 8-K: FY2026 Q1 EPS: USD -1.08
- benzinga_article · May 5 at 07:01 AM
Enveric Highlights Preclinical PTSD Data Amid Rising Focus On Mental Health Therapies
